Sophia Genetics: Ross Muken, George Cardoza

Sophia Genetics said this week that it has promoted CFO and Chief Operating Officer Ross Muken to president of the company, and has appointed George Cardoza to the CFO position.

Muken joined the company in 2021 as CFO and was appointed as CFO and COO in March 2023. He previously served as CFO and COO of Click Therapeutics. He was also previously head of healthcare services and technology research at Evercore ISI and held an equity research position at Thomas Weisel Partners.

Cardoza joins Sophia from Biocartis, where he was CFO and head of service delivery. Prior to that he spent more than 12 years at NeoGenomics Laboratories in several executive roles including CFO, president of the pharma services division, and president and COO of laboratory operations. Prior to that he spent more than 14 years at Quest Diagnostics in various roles. He holds a BS in finance and accounting from Syracuse University and an MBA from Michigan State University.